Max S. Mano
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 61
- HER2/EGFR in Cancer Research 34
- Cancer Treatment and Pharmacology 23
-
- Breast Cancer Treatment Studies 35
- Cancer Genomics and Diagnostics 10
- Co-authors
- Virginie Durbecq (6 shared papers)Evandro de Azambuja (3 shared papers)Fátima Cardoso (8 shared papers)Denis Larsimont (4 shared papers)Marianne Paesmans (4 shared papers)Ahmad Awada (14 shared papers)Christos Sotiriou (2 shared papers)Gilberto de Castro (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)The Breast (8 papers)Annals of Oncology (7 papers)Cancer Treatment Reviews (6 papers)Cancer Research (5 papers)
- Partner nations
- BrazilBelgiumUnited States
In The Last Decade
Max S. Mano
103 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 987
- Oncology 1.5k
- Reproductive Medicine 213
- Pathology and Forensic Medicine 431
- Pulmonary and Respiratory Medicine 582
Countries citing papers authored by Max S. Mano
This map shows the geographic impact of Max S. Mano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max S. Mano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max S. Mano more than expected).
Fields of papers citing papers by Max S. Mano
This network shows the impact of papers produced by Max S. Mano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max S. Mano. The network helps show where Max S. Mano may publish in the future.
Co-authors
The 25 scholars most cited alongside Max S. Mano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 109 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients Hit paper breakdown → | 2007 | 724 |
| 2 | 2005 | 272 | |
| 3 | 2015 | 231 | |
| 4 | 2007 | 144 | |
| 5 | 2007 | 81 | |
| 6 | 2013 | 66 | |
| 7 | 2006 | 65 | |
| 8 | 2006 | 50 | |
| 9 | 2006 | 49 | |
| 10 | 2004 | 44 | |
| 11 | 2004 | 42 | |
| 12 | 2003 | 37 | |
| 13 | 2004 | 37 | |
| 14 | 2008 | 32 | |
| 15 | 2018 | 31 | |
| 16 | 2002 | 29 | |
| 17 | 2016 | 28 | |
| 18 | 2021 | 26 | |
| 19 | 2004 | 26 | |
| 20 | 2023 | 23 |
About Max S. Mano
Max S. Mano is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 109 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), HER2/EGFR in Cancer Research (34 papers), Cancer Treatment and Pharmacology (23 papers), Advanced Breast Cancer Therapies (14 papers), Cancer Genomics and Diagnostics (10 papers), Breast Lesions and Carcinomas (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Ovarian cancer diagnosis and treatment (8 papers). The work is most often cited by research in Cancer Research (987 citations), Oncology (1.5k citations), Reproductive Medicine (213 citations), Pathology and Forensic Medicine (431 citations) and Pulmonary and Respiratory Medicine (582 citations). Max S. Mano has collaborated with scholars based in Brazil, Belgium and United States. Frequent co-authors include Virginie Durbecq, Evandro de Azambuja, Fátima Cardoso, Denis Larsimont, Marianne Paesmans, Ahmad Awada, Christos Sotiriou, Gilberto de Castro, M. Piccart-Gebhart and Martine Piccart. Their work appears in journals such as Journal of Clinical Oncology, The Breast, Annals of Oncology, Cancer Treatment Reviews and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.